Dynavax Technologies (DVAX)

Add to Watchlists
Create an Alert
18.25 -0.20  -1.08% NASDAQ Nov 17, 20:00 Delayed 2m USD

Dynavax Technologies Return on Equity (TTM):

-69.92% for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Dynavax Technologies Return on Equity (TTM) Chart

Export Data
Save Image
Print Image

Dynavax Technologies Historical Return on Equity (TTM) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 -69.92%
June 30, 2017 -88.86%
March 31, 2017 -92.55%
Dec. 31, 2016 -81.75%
Sept. 30, 2016 -72.59%
June 30, 2016 -72.81%
March 31, 2016 -75.53%
Dec. 31, 2015 -82.36%
Sept. 30, 2015 -87.69%
June 30, 2015 -97.56%
March 31, 2015 -82.92%
Dec. 31, 2014 -61.89%
Sept. 30, 2014 -57.81%
June 30, 2014 -50.42%
March 31, 2014 -48.55%
Dec. 31, 2013 -59.99%
Sept. 30, 2013 -74.23%
June 30, 2013 -66.70%
March 31, 2013 -64.48%
Dec. 31, 2012 -60.53%
Sept. 30, 2012 -53.75%
June 30, 2012 -61.58%
March 31, 2012 -76.00%
Dec. 31, 2011 -89.81%
Sept. 30, 2011 -153.3%
   
June 30, 2011 -144.4%
March 31, 2011 -271.1%
Dec. 31, 2010 -309.1%
Sept. 30, 2010 -617.4%
June 30, 2010 -647.5%
March 31, 2010 -343.1%
Dec. 31, 2009 -189.4%
Sept. 30, 2009 16.67%
June 30, 2009 43.15%
March 31, 2009 -21.95%
Dec. 31, 2008 -119.4%
Sept. 30, 2008 -165.3%
June 30, 2008 -162.3%
March 31, 2008 -149.8%
Dec. 31, 2007 -117.2%
Sept. 30, 2007 -118.1%
June 30, 2007 -100.5%
March 31, 2007 -90.55%
Dec. 31, 2006 -80.30%
Sept. 30, 2006 -74.77%
June 30, 2006 -66.09%
March 31, 2006 -53.93%
Dec. 31, 2005 -33.56%
Sept. 30, 2005 -28.64%
June 30, 2005 -20.24%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Advertisement

DVAX Return on Equity (TTM) Benchmarks

Companies
Puma Biotechnology
Ultragenyx Pharmaceutical -65.89%
Amicus Therapeutics -81.19%

DVAX Return on Equity (TTM) Range, Past 5 Years

Minimum -97.56% Jun 2015
Maximum -48.55% Mar 2014
Average -72.46%

DVAX Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("DVAX", "return_on_equity")
  • Last 5 data points: =YCS("DVAX", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.